Medicus Pharma to Showcase AI-Enabled Drug Development at Longwood Miami CEO Forum

Executive Chairman & CEO Dr. Raza Bokhari to participate in panel discussion on accelerating patient care

Published on Mar. 10, 2026

Got story updates? Submit your updates here. ›

Medicus Pharma Ltd., a biotech/life sciences company, announced its participation in the Longwood Miami CEO forum being held March 11-13, 2026. Dr. Raza Bokhari, Executive Chairman & CEO of Medicus, will serve on a panel titled 'Accelerating the Path to Patient Care' and highlight the company's AI-enabled drug development strategy designed to make clinical trials more cost-efficient and time-efficient.

Why it matters

Medicus Pharma's participation in the prestigious Longwood Miami CEO forum showcases the company's commitment to advancing innovative drug development approaches using AI and other emerging technologies. The panel discussion will provide a platform for Medicus to share its vision and strategies with industry leaders, potentially opening up new collaboration opportunities.

The details

During the panel discussion, Dr. Bokhari will highlight Medicus Pharma's AI-enabled drug development strategy, which aims to streamline the clinical trial process and accelerate the path to patient care. The company's approach leverages data-driven insights to optimize clinical site selection, patient stratification, and enrollment forecasting, ultimately reducing the time and cost associated with drug development.

  • The Longwood Miami CEO forum will be held from March 11-13, 2026.
  • Dr. Bokhari's panel discussion is scheduled for March 12, 2026.

The players

Medicus Pharma Ltd.

A biotech/life sciences company focused on advancing the clinical development of novel and potentially disruptive therapeutics assets.

Dr. Raza Bokhari

The Executive Chairman and CEO of Medicus Pharma Ltd.

Longwood Miami CEO Forum

An invitation-only event that brings together industry leaders, innovators, and thought leaders to discuss the latest trends and developments in the healthcare and life sciences sectors.

Lindsay Edwards

The CTO and President of Platform at Relation Therapeutics, who will also participate in the panel discussion.

Julie Gerberding

The CEO of the Foundation for the NIH and former Director of the CDC, who will also participate in the panel discussion.

Gilmore O'Neill

The CEO of Editas Medicine, who will also participate in the panel discussion.

Jon Cohen

The Head of Life Sciences Go-To-Market at ServiceNow, who will moderate the panel discussion.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, Grocery employee (Instagram)

The takeaway

Medicus Pharma's participation in the Longwood Miami CEO forum underscores the company's commitment to leveraging innovative technologies, such as AI, to streamline drug development and accelerate the delivery of new treatments to patients. This event provides a valuable platform for Medicus to showcase its capabilities and explore potential collaborations that could further advance its pipeline of novel therapeutics.